Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Moderna Shares Rise 13% Ahead of Third-Quarter Results Friday

Summary by TokenPost
The WHO vaccine advisory group recommended adding mRNA-1469 to an ongoing Phase 2/3 Ebola trial. Data for a separate cancer therapy are slated for an oral presentation.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

TokenPostTokenPost

Moderna Shares Rise 13% Ahead of Third-Quarter Results Friday

The WHO vaccine advisory group recommended adding mRNA-1469 to an ongoing Phase 2/3 Ebola trial. Data for a separate cancer therapy are slated for an oral presentation.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

TokenPost broke the news on Thursday, November 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

World Health Organization icon

World Health Organization

Cambridge, Massachusetts icon

Cambridge, Massachusetts

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal